PP

Parthil Paragbhai Shukal

Active Director Director DIN 11466101
DIN 11466101 First appointment Jan 2026 Primary industry Business Outsourcing
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value •••• Premium profile

About Parthil Paragbhai Shukal

Data last updated:

Parthil Paragbhai Shukal is a Director at Nivagen Pharma (India) Private Limited (since 2026). The company operates in Business Outsourcing. Nivagen Pharma (India) Private Limited reported revenue of ₹11.21 Cr (FY 2024).

DIN 11466101
Primary Designation Director
Industry Business Outsourcing
First Appointment 16 Jan 2026
Oldest Company Age 8 yrs
Largest company Nivagen Pharma (India) Private Limited · ₹11.21 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Jan 20262018₹11.21 Cr (FY 2024)Active

Board colleagues of Parthil Paragbhai Shukal

NameDINCompanyDesignation
Jwalant Shukla08249559Nivagen Pharma (India) Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nivagen Pharma (India) Private Limited
Premium access

Shareholding and investment profile for Parthil Paragbhai Shukal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Parthil Paragbhai Shukal

Parthil Paragbhai Shukal currently holds 1 directorship: Nivagen Pharma (India) Private Limited (Director, since 16 Jan 2026, revenue ₹11.21 Cr (FY 2024)).

Parthil Paragbhai Shukal was first appointed on 16 Jan 2026 as Director at Nivagen Pharma (India) Private Limited.

The current boards of Parthil Paragbhai Shukal's companies include Jwalant Shukla (Nivagen Pharma (India) Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available